Medlab Clinical Ltd (ASX: MDC) Share Price and News
Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)
() Chart and Price Data
Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range
-
Days Range
-
Turnover
Fundamental Company Figures
Data provided by Morningstar.
Market Cap
$81.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Shares Outstanding
279.68 million
Earnings per share
-0.046
Dividend per share
N/A
Year To Date Return
33.33%
Earnings Yield
N/A
Franking
N/A
Medlab Clinical Ltd (ASX: MDC) Latest News
Here’s why the Medlab (ASX:MDC) share price is rising today
Aaron Teboneras | February 18, 2021 2:09pm
Why Clean TeQ, Medlab, Newcrest, & Ramelius are storming higher today
James Mickleboro | March 9, 2020 11:42am
Why this ASX cannabis share is shooting 15% higher today
James Mickleboro | March 9, 2020 10:27am
Why THC Global and these ASX cannabis shares are rocketing higher today
James Mickleboro | November 11, 2019 10:46am
Why Medlab, Metcash, SKY and Space Global, and WiseTech shares charged higher today
James Mickleboro | March 5, 2019 2:04pm
These small cap ASX shares are on the rise today
James Mickleboro | September 11, 2018 12:10pm
Recent Stock Announcements
Price Sensitive OnlyAn announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
| Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
|---|---|---|---|---|---|
About Medlab Clinical Ltd (ASX: MDC)
Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.
Share Price History
Data provided by Morningstar.| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 05 Mar 2021 | $0.29 | $-0.02 | -6.45% | 642,466 | $0.31 | $0.31 | $0.29 |
| 04 Mar 2021 | $0.31 | $-0.01 | -3.13% | 312,200 | $0.32 | $0.32 | $0.31 |
| 03 Mar 2021 | $0.32 | $-0.01 | -3.08% | 307,547 | $0.33 | $0.33 | $0.32 |
| 02 Mar 2021 | $0.33 | $-0.01 | -3.03% | 138,274 | $0.33 | $0.34 | $0.33 |
| 01 Mar 2021 | $0.33 | $0.01 | 3.08% | 219,600 | $0.32 | $0.34 | $0.32 |
| 26 Feb 2021 | $0.33 | $0.00 | 0.00% | 328,907 | $0.33 | $0.33 | $0.32 |
| 25 Feb 2021 | $0.33 | $-0.01 | -2.99% | 206,902 | $0.34 | $0.34 | $0.33 |
| 24 Feb 2021 | $0.34 | $-0.01 | -2.90% | 613,708 | $0.36 | $0.36 | $0.33 |
| 23 Feb 2021 | $0.35 | $-0.02 | -5.56% | 135,646 | $0.36 | $0.36 | $0.35 |
| 22 Feb 2021 | $0.36 | $0.03 | 9.09% | 645,460 | $0.36 | $0.36 | $0.34 |
| 19 Feb 2021 | $0.33 | $-0.02 | -5.71% | 656,439 | $0.35 | $0.36 | $0.32 |
| 18 Feb 2021 | $0.35 | $0.03 | 9.23% | 1,179,365 | $0.35 | $0.36 | $0.33 |
| 17 Feb 2021 | $0.33 | $-0.02 | -5.88% | 149,805 | $0.34 | $0.34 | $0.32 |
| 16 Feb 2021 | $0.34 | $0.00 | 0.00% | 604,094 | $0.35 | $0.35 | $0.31 |
| 15 Feb 2021 | $0.35 | $0.02 | 6.06% | 477,067 | $0.34 | $0.35 | $0.34 |
| 12 Feb 2021 | $0.33 | $-0.02 | -5.71% | 558,324 | $0.35 | $0.35 | $0.32 |
| 11 Feb 2021 | $0.35 | $0.05 | 16.67% | 1,258,672 | $0.34 | $0.35 | $0.34 |
| 10 Feb 2021 | $0.30 | $-0.02 | -6.25% | 559,501 | $0.32 | $0.32 | $0.30 |
| 09 Feb 2021 | $0.32 | $0.00 | 0.00% | 214,718 | $0.33 | $0.33 | $0.31 |
| 08 Feb 2021 | $0.32 | $-0.01 | -3.08% | 660,550 | $0.33 | $0.34 | $0.32 |
| 05 Feb 2021 | $0.33 | $0.01 | 3.17% | 564,961 | $0.33 | $0.33 | $0.31 |
| 04 Feb 2021 | $0.32 | $0.01 | 3.23% | 415,701 | $0.32 | $0.32 | $0.31 |
| 03 Feb 2021 | $0.31 | $0.01 | 3.33% | 408,209 | $0.31 | $0.33 | $0.31 |
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.
Show more
Top Share Holders
Data provided by Morningstar.| Name | Shares | Capital |
|---|---|---|
| Sean Michael Hall | 57,925,555 | 20.71% |
| Farjoy Pty Ltd | 30,849,322 | 11.03% |
| Fit Investments Pty Ltd <Hallab Investment A/C> | 12,334,445 | 4.41% |
| Realm Group Pty Ltd | 10,500,000 | 3.75% |
| UBS Nominees Pty Ltd | 9,255,665 | 3.31% |
| J P Morgan Nominees Australia Pty Limited | 7,203,560 | 2.58% |
| HSBC Custody Nominees (Australia) Limited | 6,455,054 | 2.31% |
| Richard Albarran <Albarran Family No 2 A/C> | 5,555,553 | 1.99% |
| United Trolley Collections P/L | 4,945,500 | 1.77% |
| Citicorp Nominees Pty Limited | 4,061,331 | 1.45% |
| Rolay Pty Ltd | 3,750,000 | 1.34% |
| Mr Michael Jack Hall + Mrs Elizabeth Ann Jones <Hall Jones Super Fund A/C> | 3,572,938 | 1.28% |
| Villamagna Inc | 3,000,000 | 1.07% |
| Acron Holdings Pty Limited <Acron Super Fund A/C> | 2,840,055 | 1.02% |
| Netwealth Investments Limited | 2,303,463 | 0.82% |
| D J Fairfull Pty Ltd <Fairfull Super Fund A/C> | 1,897,534 | 0.68% |
| Equitas Nominees Pty Ltd | 1,850,000 | 0.66% |
| Rolay Pty Limited | 1,805,553 | 0.65% |
| Legend Developments Pty Ltd <A&D Dworkin Family A/C> | 1,761,111 | 0.63% |
| BNP Paribas Nominees Pty Ltd | 1,630,323 | 0.58% |